3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 4
1
Phase 3
1
Phase 2/3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Breast Neoplasms
4
Neutropenia
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Early Stage Breast Cancer
2
Waldenstrom Macroglobulinemia
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Myelodysplastic Syndromes
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Eosinophilic, Acute
1
Leukemia, Basophilic, Acute
1
Hodgkin Disease
1
Graft vs Host Disease
1
Febrile Neutropenia
1
Interventions
Meropenem
6
Ceftazidime
5
Vancomycin
4
Ciprofloxacin
3
Cefepime
3
Teicoplanin
2
Levofloxacin
2
Amikacin
2
ceftolozane, tazobactam drug combination
1
Vaccination
1
Tazobactam
1
Simvastatin
1
Pneumococcal Vaccines
1
Piperacillin, Tazobactam Drug Combination
1
Piperacillin
1
Ofloxacin
1
Micafungin
1
Metronidazole
1
Injections
1
Filgrastim
1
Cilastatin, Imipenem Drug Combination
1
Anti-Bacterial Agents
1
Amoxicillin-Potassium Clavulanate Combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Febrile Neutropenia
×
Filgrastim
×
Clear all
NCT01222819
2016-04-06
G-CSF
Rabin Medical Center
Phase 4
Terminated
120 enrolled